Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV.
Humans
HIV Infections
/ drug therapy
Serum Amyloid P-Component
/ metabolism
Male
Female
C-Reactive Protein
/ analysis
Adult
Chemokine CCL4
/ blood
Interleukin-6
/ blood
Middle Aged
Biomarkers
/ blood
Chemokine CXCL10
/ blood
Antiretroviral Therapy, Highly Active
Treatment Outcome
Anti-Retroviral Agents
/ therapeutic use
CD4-CD8 Ratio
Anti-HIV Agents
/ therapeutic use
HIV infection
IL-6
IP-10
MIP-1β
PTX-3
immunologic response
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
12
06
2024
accepted:
13
08
2024
medline:
13
9
2024
pubmed:
13
9
2024
entrez:
13
9
2024
Statut:
epublish
Résumé
Despite effective antiretroviral therapy (ART), 15-30% of people with HIV experience poor CD4
Identifiants
pubmed: 39267754
doi: 10.3389/fimmu.2024.1447926
pmc: PMC11390504
doi:
Substances chimiques
Serum Amyloid P-Component
0
PTX3 protein
148591-49-5
C-Reactive Protein
9007-41-4
Chemokine CCL4
0
Interleukin-6
0
CCL4 protein, human
0
Biomarkers
0
Chemokine CXCL10
0
CXCL10 protein, human
0
IL6 protein, human
0
Anti-Retroviral Agents
0
Anti-HIV Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1447926Informations de copyright
Copyright © 2024 Mejías-Trueba, Saborido-Alconchel, Serna-Gallego, Trujillo-Rodríguez, Muñoz-Muela, Llaves-Flores, Espinosa, Roca-Oporto, Herrero, Sotomayor and López-Cortes.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):395-402
pubmed: 26115437
Lancet HIV. 2015 Mar;2(3):e98-106
pubmed: 26424550
PLoS One. 2015 Mar 19;10(3):e0115019
pubmed: 25790185
Antiviral Res. 2017 Jun;142:76-82
pubmed: 28343846
Expert Rev Anti Infect Ther. 2016;14(1):29-40
pubmed: 26513236
J Clin Epidemiol. 2003 Nov;56(11):1129-35
pubmed: 14615004
AIDS. 2016 Mar 27;30(6):899-908
pubmed: 26959354
J Infect Dis. 2017 Jul 1;216(1):82-91
pubmed: 28498953
Int J STD AIDS. 1997 Jul;8(7):423-6
pubmed: 9228588
HIV Med. 2010 Feb;11(2):152-60
pubmed: 19732175
PLoS One. 2015 Jun 25;10(6):e0125248
pubmed: 26110761
Sci Rep. 2020 Feb 19;10(1):2937
pubmed: 32076107
Viral Immunol. 2012 Aug;25(4):333-7
pubmed: 22788418
PLoS One. 2018 Oct 22;13(10):e0205777
pubmed: 30346965
AIDS Res Hum Retroviruses. 2024 Feb;40(2):110-113
pubmed: 37335044